[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK0722316T3 - Nyt emulsionspræparat - Google Patents

Nyt emulsionspræparat

Info

Publication number
DK0722316T3
DK0722316T3 DK94929711T DK94929711T DK0722316T3 DK 0722316 T3 DK0722316 T3 DK 0722316T3 DK 94929711 T DK94929711 T DK 94929711T DK 94929711 T DK94929711 T DK 94929711T DK 0722316 T3 DK0722316 T3 DK 0722316T3
Authority
DK
Denmark
Prior art keywords
pct
formulation
sec
optionally
emulsion preparation
Prior art date
Application number
DK94929711T
Other languages
English (en)
Inventor
Stefan Lundquist
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of DK0722316T3 publication Critical patent/DK0722316T3/da

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Cosmetics (AREA)
DK94929711T 1993-10-07 1994-10-05 Nyt emulsionspræparat DK0722316T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303281A SE9303281D0 (sv) 1993-10-07 1993-10-07 New formulation
PCT/SE1994/000926 WO1995009609A1 (en) 1993-10-07 1994-10-05 New emulsion formulation

Publications (1)

Publication Number Publication Date
DK0722316T3 true DK0722316T3 (da) 2000-06-13

Family

ID=20391342

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94929711T DK0722316T3 (da) 1993-10-07 1994-10-05 Nyt emulsionspræparat

Country Status (31)

Country Link
US (2) US5843465A (da)
EP (1) EP0722316B1 (da)
JP (1) JPH09504279A (da)
CN (1) CN1134663A (da)
AT (1) ATE189119T1 (da)
AU (1) AU701512B2 (da)
BR (1) BR9407748A (da)
CA (1) CA2172143A1 (da)
CZ (1) CZ94396A3 (da)
DE (1) DE69422818T2 (da)
DK (1) DK0722316T3 (da)
EE (1) EE03235B1 (da)
EG (1) EG20540A (da)
ES (1) ES2145158T3 (da)
FI (1) FI961525A (da)
GR (1) GR3033255T3 (da)
HK (1) HK1009257A1 (da)
HU (1) HUT74638A (da)
IL (1) IL111131A (da)
IS (1) IS4209A (da)
MA (1) MA23344A1 (da)
NO (1) NO961363D0 (da)
NZ (1) NZ274583A (da)
PL (1) PL313767A1 (da)
PT (1) PT722316E (da)
SE (1) SE9303281D0 (da)
SG (1) SG47896A1 (da)
SK (1) SK39396A3 (da)
TN (1) TNSN94099A1 (da)
WO (1) WO1995009609A1 (da)
ZA (1) ZA947351B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US20020086857A1 (en) * 2000-09-15 2002-07-04 Mcdonald George B. Method of long-term treatment of graft-versus-host disease using topical active corticosterioids
US20100184732A1 (en) * 2000-09-15 2010-07-22 Mcdonald George Method of long-term treatment of graft-versus-host disease using topical active corticosteroids
DE10059430A1 (de) * 2000-11-30 2002-06-06 Cognis Deutschland Gmbh Feinteilige Emulsionen
WO2002102311A2 (en) 2001-06-15 2002-12-27 Cornerstone Pharmaceuticals Nanoparticles for treating targeted tissues and cells
IL160103A0 (en) * 2001-08-06 2004-06-20 Astrazeneca Ab Aqueous dispersion comprising stable nanoparticles of a water-insoluble active substance and an excipient like middle chain triglycerides (mct)
TWI248159B (en) * 2002-01-25 2006-01-21 Nanya Technology Corp Manufacturing method for shallow trench isolation with high aspect ratio
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
US8685428B2 (en) * 2002-12-10 2014-04-01 Advanced Cardiovascular Systems, Inc. Therapeutic composition and a method of coating implantable medical devices
GB0230088D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0230087D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0302671D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302672D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302673D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
EP1641779A1 (en) * 2003-06-18 2006-04-05 AstraZeneca AB 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator.
GB0314057D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314261D0 (en) * 2003-06-19 2003-07-23 Astrazeneca Ab Therapeutic agents
US20070140999A1 (en) * 2003-07-18 2007-06-21 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
US7169401B2 (en) * 2003-07-18 2007-01-30 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
US20060099173A1 (en) * 2003-10-24 2006-05-11 Nancy Puglia Topical skin care composition
US20070207107A1 (en) * 2006-03-03 2007-09-06 Gareth Winckle Silicone based emulsions for topical drug delivery
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンe↓1脂肪乳剤
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 4−ビフエニリル酢酸系化合物含有脂肪乳剤
US4760096A (en) * 1985-09-27 1988-07-26 Schering Corporation Moisturizing skin preparation
DE3623376A1 (de) * 1986-07-11 1988-01-21 Behringwerke Ag Pharmazeutische formulierung und verfahren zu deren herstellung
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
JP2785981B2 (ja) * 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition

Also Published As

Publication number Publication date
EE03235B1 (et) 1999-12-15
ZA947351B (en) 1995-04-10
IL111131A0 (en) 1994-12-29
NO961363L (no) 1996-04-02
AU7866794A (en) 1995-05-01
EP0722316A1 (en) 1996-07-24
CZ94396A3 (en) 1996-06-12
US5843465A (en) 1998-12-01
HK1009257A1 (en) 1999-05-28
HUT74638A (en) 1997-01-28
SK39396A3 (en) 1997-02-05
JPH09504279A (ja) 1997-04-28
ATE189119T1 (de) 2000-02-15
NO961363D0 (no) 1996-04-02
MA23344A1 (fr) 1995-07-01
PL313767A1 (en) 1996-07-22
WO1995009609A1 (en) 1995-04-13
AU701512B2 (en) 1999-01-28
TNSN94099A1 (fr) 1995-04-25
SG47896A1 (en) 1998-04-17
IS4209A (is) 1995-04-08
HU9600900D0 (en) 1996-05-28
PT722316E (pt) 2000-06-30
ES2145158T3 (es) 2000-07-01
EP0722316B1 (en) 2000-01-26
SE9303281D0 (sv) 1993-10-07
BR9407748A (pt) 1997-11-11
DE69422818T2 (de) 2000-07-27
EG20540A (en) 1999-07-31
FI961525A0 (fi) 1996-04-04
CA2172143A1 (en) 1995-04-13
CN1134663A (zh) 1996-10-30
US5660837A (en) 1997-08-26
GR3033255T3 (en) 2000-09-29
DE69422818D1 (de) 2000-03-02
IL111131A (en) 1999-09-22
NZ274583A (en) 1998-01-26
FI961525A (fi) 1996-04-04

Similar Documents

Publication Publication Date Title
DK0722316T3 (da) Nyt emulsionspræparat
SE9503143D0 (sv) New preparation
ATE213940T1 (de) Parenteral anzuwendende arzneizubereitung enthaltend amiodaron
ATE213158T1 (de) Pharmazeutische emulsion
ES2098920T3 (es) Formulaciones farmaceuticas para el tratamiento de la dependencia a la nicotina.
SE9402880D0 (sv) New peptide derivatives
ATE153342T1 (de) Adenosinderivate, verfahren zu deren herstellung und pharmazeutische mittel
SE9502219D0 (sv) Novel medical use